NA Acute Myeloid Leukemia Diagnostics Market - Industry Trends and Forecast to 2035
North America acute myeloid leukemia diagnostics market is projected to register a substantial CAGR of 11.4% in the forecast period of 2024 to 2031. The new market report contains data for the historic year 2022, the base year of calculation is 2023, and the forecast period is 2024 to 2031.
Market Segmentation
North America Acute Myeloid Leukemia Diagnostics Market, By Product Type (Instruments, and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Bone Marrow Test, Biomarker Test, Immunophenotyping, Genetic Testing and Others), Cancer Type (Myeloblastic (M0), Myeloblastic (M1), Myeloblastic (M2), Promyelocytic (M3), Myelomonocytic (M4), MONOCYTIC (M5), Erythroleukemia (M6) and Megakaryocytic (M7)), Age Group (Below 21, 21-29, 30-65, 65 and Above), Gender (Male and Female) End User (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2031
Driver
• Increasing diagnostic products for leukemia cancer
Restrain
• Late diagnosis and Poor prognosis of leukemia
Opportunity
• Initiatives by government and other authorities for life sciences and funding
Market Players
Some of the major market players in North America acute myeloid leukemia diagnostics market are listed below:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific, Inc.
• QIAGEN
• Abbott
• Siemens Healthcare GmbH
• Hologic, Inc.
• Agilent Technologies, Inc.
• DiaSorin S.p.A.
• Illumina, Inc.
• BIOMÉRIEUX
• Myriad Genetics, Inc.
• Quest Diagnostics Incorporated.
• Bio-Rad Laboratories, Inc.
• Koninklijke Philips N.V.
• BD
• Exact Sciences Corporation
• Time Medical Holding
• PlexBio
• MinFound Medical Systems Co., Ltd
• Medonica Co. LTD
• CANON MEDICAL SYSTEMS CORPORATION
• Sysmex Corporation
• Epigenomics AG
• Sonic Healthcare
• SternMed GmbH
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The North America Acute Myeloid Leukemia Diagnostics Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter’s Five Forces
- 4.3 Epidemiology
- 5 North America Acute Myeloid Leukemia Diagnostics Market, Regulations
- 5.1 Regulatory Scenario In The U.S.
- 5.2 Regulatory Scenario In Australia
- 5.3 Regulatory Scenario In Japan
- 5.4 Regulatory Scenario In China
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Growing Prevalence Of Leukemia Cancer
- 6.1.2 Novel Technological Advancements In Leukemia Diagnostics
- 6.1.3 Rising Preference For Preventive Health Check-ups
- 6.1.4 Increase In Awareness Regarding Leukemia Cancer
- 6.2 Restraints
- 6.2.1 Strict Regulations And Standards For The Approval And Commercialization Of Leukemia Diagnostic Products
- 6.2.2 Late Diagnosis And Poor Prognosis Of Leukemia
- 6.3 Opportunities
- 6.3.1 Increase In Diagnostic Products For Leukemia
- 6.3.2 Rise In Healthcare Expenditure For Cancer Diagnosis And Treatment
- 6.3.3 Government Initiatives Toward Cancer Diagnostics
- 6.4 Challenges
- 6.4.1 Increased Cost, Safety, And Convenience Issues
- 6.4.2 Lack Of Skilled And Certified Professionals
- 7 North America Acute Myeloid Leukemia Diagnostics Market, By Product Type
- 7.1 Overview
- 7.2 Instruments
- 7.2.1 Biopsy Instruments
- 7.2.1.1 Bone Marrow Biopsy
- 7.2.1.2 Needle Biopsy
- 7.2.1.3 Surgical Biopsy
- 7.2.1.4 Others
- 7.2.2 Pathology-based Instruments
- 7.2.2.1 Pcr Instruments
- 7.2.2.2 Slide Staining Systems
- 7.2.2.3 Tissue Processing Systems
- 7.2.2.4 Cell Processors
- 7.2.2.5 Other Pathology-based Instruments
- 7.2.3 Imaging Instruments
- 7.2.3.1 Ultrasound Systems
- 7.2.3.2 Ct Systems
- 7.2.3.3 Mri Systems
- 7.2.3.4 Others
- 7.2.4 Others
- 7.3 Consumables & Accessories
- 7.3.1 Kits
- 7.3.1.1 Pcr Kits
- 7.3.1.2 Dna Polymerase Kits
- 7.3.1.3 Nucleic Acid Isolation Kits
- 7.3.1.4 Others
- 7.3.2 Reagents
- 7.3.2.1 Assays
- 7.3.2.2 Buffers
- 7.3.2.3 Primers
- 7.3.2.4 Others
- 7.3.3 Probes
- 7.3.4 Other Consumables
- 8 North America Acute Myeloid Leukemia Diagnostics Market, By Test Type
- 8.1 Overview
- 8.2 Blood Test
- 8.2.1 Complete Blood Count (Cbc)
- 8.2.2 Blood Chemistry Tests
- 8.2.3 Others
- 8.3 Imaging Test
- 8.3.1 Computed Tomography (Ct) Scan
- 8.3.2 Mri
- 8.3.3 Positron Emission Tomography (Pet) Scan
- 8.3.4 Others
- 8.4 Bone Marrow Tests
- 8.4.1 Bone Marrow Aspirate
- 8.4.2 Bone Marrow Biopsy
- 8.4.3 Others
- 8.5 Genetic Tests
- 8.5.1 Fluorescence In Situ Hybridization (Fish)
- 8.5.2 Karyotyping
- 8.5.3 Others
- 8.6 Biomarker Test
- 8.6.1 Genetic Acute Myeloid Leukemia (Aml) Biomarker
- 8.6.2 Epigenetic Acute Myeloid Leukemia (Aml) Biomarker
- 8.6.3 Proteomic Acute Myeloid Leukemia (Aml) Biomarker
- 8.7 Immunophenotyping
- 8.7.1 Flow Cytometry
- 8.7.2 Immunohistochemistry
- 8.7.3 Others
- 8.8 Others
- 9 North America Acute Myeloid Leukemia Diagnostics Market, By Cancer Type
- 9.1 Overview
- 9.2 Myeloblastic (M0)
- 9.3 Myeloblastic (M1)
- 9.4 Myeloblastic (M2)
- 9.5 Promyelocytic (M3)
- 9.6 Myelomonocytic (M4)
- 9.7 Monocytic (M5)
- 9.8 Erythroleukemia (M6)
- 9.9 Megakaryocytic (M7)
- 10 North America Acute Myeloid Leukemia Diagnostics Market, By Age Group
- 10.1 Overview
- 10.2 65 And Above
- 10.3 30-65
- 10.4 Below 21
- 10.5 21-29
- 11 North America Acute Myeloid Leukemia Diagnostics Market, By Gender
- 11.1 Overview
- 11.2 Male
- 11.3 Female
- 12 North America Acute Myeloid Leukemia Diagnostics Market, By End User
- 12.1 Overview
- 12.2 Hospitals
- 12.3 Associated Labs
- 12.4 Independent Diagnostic Laboratories
- 12.5 Diagnostic Imaging Centers
- 12.6 Cancer Research Institutes
- 12.7 Others
- 13 North America Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel
- 13.1 Overview
- 13.2 Direct Tender
- 13.3 Retail Sales
- 14 North America Acute Myeloid Leukemia Diagnostics Market, By Region
- 14.1 North America
- 14.1.1 U.S.
- 14.1.2 Canada
- 14.1.3 Mexico
- 15 North America Acute Myeloid Leukemia Diagnostics Market: Company Landscape
- 15.1 Company Share Analysis: North America
- 16 Swot Analysis
- List Of Tables
- Table 1 Approved Diagnostics Of Leukemia
- Table 2 North America Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 3 North America Instruments In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 4 North America Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 5 North America Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 6 North America Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 7 North America Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 8 North America Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 9 North America Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 10 North America Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 11 North America Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 12 North America Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 13 North America Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 14 North America Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 15 North America Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 16 North America Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 17 North America Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 18 North America Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 19 North America Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 20 North America Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 21 North America Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 22 North America Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 23 North America Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 24 North America Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 25 North America Others In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 26 North America Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 27 North America Myeloblastic (M0) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 28 North America Myeloblastic (M1) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 29 North America Myeloblastic (M2) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 30 North America Promyelocytic (M3) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 31 North America Myelomonocytic (M4) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 32 North America Monocytic (M5) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 33 North America Erythroleukemia (M6) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 34 North America Megakaryocytic (M7) Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 35 North America Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 36 North America 65 And Above In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 37 North America 30-65 In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 38 North America Below 21 In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 39 North America 21-29 In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 40 North America Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 41 North America Male In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 42 North America Female In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 43 North America Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 44 North America Hospitals In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 45 North America Associated Labs In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 46 North America Independent Diagnostic Laboratories In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 47 North America Diagnostic Imaging Centers In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 48 North America Cancer Research Institutes In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 49 North America Others In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 50 North America Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 51 North America Direct Tender In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 52 North America Retail Sales In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 53 North America Acute Myeloid Leukemia Diagnostics Market, By Country, 2022-2031 (Usd Million)
- Table 54 North America Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 55 North America Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 56 North America Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 57 North America Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 58 North America Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 59 North America Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 60 North America Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 61 North America Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 62 North America Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 63 North America Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 64 North America Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 65 North America Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 66 North America Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 67 North America Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 68 North America Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 69 North America Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 70 North America Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 71 North America Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 72 North America Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 73 North America Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 74 U.S. Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 75 U.S. Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 76 U.S. Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 77 U.S. Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 78 U.S. Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 79 U.S. Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 80 U.S. Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 81 U.S. Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 82 U.S. Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 83 U.S. Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 84 U.S. Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 85 U.S. Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 86 U.S. Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 87 U.S. Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 88 U.S. Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 89 U.S. Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 90 U.S. Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 91 U.S. Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 92 U.S. Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 93 U.S. Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 94 Canada Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 95 Canada Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 96 Canada Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 97 Canada Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 98 Canada Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 99 Canada Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 100 Canada Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 101 Canada Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 102 Canada Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 103 Canada Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 104 Canada Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 105 Canada Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 106 Canada Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 107 Canada Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 108 Canada Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 109 Canada Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 110 Canada Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 111 Canada Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 112 Canada Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 113 Canada Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 114 Mexico Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 115 Mexico Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 116 Mexico Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 117 Mexico Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 118 Mexico Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 119 Mexico Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 120 Mexico Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 121 Mexico Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 122 Mexico Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 123 Mexico Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 124 Mexico Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 125 Mexico Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 126 Mexico Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 127 Mexico Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 128 Mexico Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 129 Mexico Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 130 Mexico Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 131 Mexico Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 132 Mexico Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 133 Mexico Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- List Of Figures
- Figure 1 North America Acute Myeloid Leukemia Diagnostics Market: Segmentation
- Figure 2 North America Acute Myeloid Leukemia Diagnostics Market: Data Triangulation
- Figure 3 North America Acute Myeloid Leukemia Diagnostics Market: Droc Analysis
- Figure 4 North America Acute Myeloid Leukemia Diagnostics Market: North America Vs Regional Market Analysis
- Figure 5 North America Acute Myeloid Leukemia Diagnostics Market: Company Research Analysis
- Figure 6 North America Acute Myeloid Leukemia Diagnostics Market: Interview Demographics
- Figure 7 North America Acute Myeloid Leukemia Diagnostics Market : Dbmr Market Position Grid
- Figure 8 North America Acute Myeloid Leukemia Diagnostics Market: Market End User Coverage Grid
- Figure 9 North America Acute Myeloid Leukemia Diagnostics Market: Vendor Share Analysis
- Figure 10 North America Acute Myeloid Leukemia Diagnostics Market: Segmentation
- Figure 11 The Growing Prevalence Of Leukemia Cancer Is Expected To Drive The North America Acute Myeloid Leukemia Diagnostics Market In The Forecast Period
- Figure 12 The Instruments Segment Is Expected To Account For The Largest Share Of The North America Acute Myeloid Leukemia Diagnostics Market In 2024 & 2031
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Acute Myeloid Leukemia Diagnostics Market
- Figure 14 Number Of Prevalence Of Leukemia Incidence Worldwide (Both Sexes)
- Figure 15 Five Years Prevalence Leukemia Incidence Worldwide (Both Sexes)
- Figure 16 North America Acute Myeloid Leukemia Diagnostics Market: By Product Type, 2023
- Figure 17 North America Acute Myeloid Leukemia Diagnostics Market: By Product Type, 2024-2031 (Usd Million)
- Figure 18 North America Acute Myeloid Leukemia Diagnostics Market: By Product Type, Cagr (2024-2031)
- Figure 19 North America Acute Myeloid Leukemia Diagnostics Market: By Product Type, Lifeline Curve
- Figure 20 North America Acute Myeloid Leukemia Diagnostics Market: By Test Type, 2023
- Figure 21 North America Acute Myeloid Leukemia Diagnostics Market: By Test Type, 2024-2031 (Usd Million)
- Figure 22 North America Acute Myeloid Leukemia Diagnostics Market: By Test Type, Cagr (2024-2031)
- Figure 23 North America Acute Myeloid Leukemia Diagnostics Market: By Test Type, Lifeline Curve
- Figure 24 North America Acute Myeloid Leukemia Diagnostics Market: By Cancer Type, 2023
- Figure 25 North America Acute Myeloid Leukemia Diagnostics Market: By Cancer Type, 2024-2031 (Usd Million)
- Figure 26 North America Acute Myeloid Leukemia Diagnostics Market: By Cancer Type, Cagr (2024-2031)
- Figure 27 North America Acute Myeloid Leukemia Diagnostics Market: By Cancer Type, Lifeline Curve
- Figure 28 North America Acute Myeloid Leukemia Diagnostics Market: By Age Group, 2023
- Figure 29 North America Acute Myeloid Leukemia Diagnostics Market: By Age Group, 2024-2031 (Usd Million)
- Figure 30 North America Acute Myeloid Leukemia Diagnostics Market: By Age Group, Cagr (2024-2031)
- Figure 31 North America Acute Myeloid Leukemia Diagnostics Market: By Age Group, Lifeline Curve
- Figure 32 North America Acute Myeloid Leukemia Diagnostics Market: By Gender, 2023
- Figure 33 North America Acute Myeloid Leukemia Diagnostics Market: By Gender, 2024-2031 (Usd Million)
- Figure 34 North America Acute Myeloid Leukemia Diagnostics Market: By Gender, Cagr (2024-2031)
- Figure 35 North America Acute Myeloid Leukemia Diagnostics Market: By Gender, Lifeline Curve
- Figure 36 North America Acute Myeloid Leukemia Diagnostics Market: By End User, 2023
- Figure 37 North America Acute Myeloid Leukemia Diagnostics Market: By End User, 2024-2031 (Usd Million)
- Figure 38 North America Acute Myeloid Leukemia Diagnostics Market: By End User, Cagr (2024-2031)
- Figure 39 North America Acute Myeloid Leukemia Diagnostics Market: By End User, Lifeline Curve
- Figure 40 North America Acute Myeloid Leukemia Diagnostics Market: By Distribution Channel, 2023
- Figure 41 North America Acute Myeloid Leukemia Diagnostics Market: By Distribution Channel, 2024-2031 (Usd Million)
- Figure 42 North America Acute Myeloid Leukemia Diagnostics Market: By Distribution Channel, Cagr (2024-2031)
- Figure 43 North America Acute Myeloid Leukemia Diagnostics Market: By Distribution Channel, Lifeline Curve
- Figure 44 North America Acute Myeloid Leukemia Diagnostics Market: Snapshot (2023)
- Figure 45 North America Acute Myeloid Leukemia Diagnostics Market: Company Share 2023(%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook